Gates Says Korean Firm Could Make 200 Million Vaccines by June
- Microsoft co-founder sends letter to President Moon Jae-in
- Gates backs SK Bioscience in effort to develop vaccine
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
SK Bioscience, the South Korean pharmaceutical company backed by Bill Gates, may be capable of producing 200 million coronavirus vaccine kits by next June, the Microsoft Corp. co-founder said in a letter to South Korean President Moon Jae-in.